Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-35,765
Closed -$1.37M 39
2023
Q2
$1.37M Buy
35,765
+22,126
+162% +$818K 0.07% 368
2023
Q1
$559K Buy
+13,639
New +$569K 0.02% 698
2022
Q1
Sell
-5,731
Closed -$274K 1171
2021
Q4
$274K Buy
+5,731
New +$257K 0.01% 893
2021
Q3
Sell
-40,927
Closed -$1.85M 1151
2021
Q2
$1.85M Buy
+40,927
New +$1.91M 0.04% 378

Other funds holding ADNT

Ergoteles's ADNT Position: Q3 2023 in Review

Ergoteles sold out of Adient (ADNT) in Q3 2023, closing a stake of 35,765 shares — an estimated $1.37M sold.

Ergoteles first reported a position in ADNT in Q2 2021 and held it in 4 quarters. The position peaked at $1.85M in Q2 2021. 290 funds tracked by Wall St. Rank hold ADNT as of Q3 2023.

  • Ergoteles reported no remaining Adient position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 35,765 Adient shares in Q3 2023, an estimated $1.37M.
  • Ergoteles first reported a position in Adient in Q2 2021 and held it in 4 quarters.
  • Ergoteles's Adient position peaked at $1.85M in Q2 2021.
  • 290 funds tracked by Wall St. Rank held Adient as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.